Innospec Zukünftiges Wachstum

NasdaqGS:IOSP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,000	165	113	168	2
12/31/2025	1,900	145	86	141	3
12/31/2024	1,826	138	160	217	3
9/30/2024	1,873	144	169	231	N/A
6/30/2024	1,894	150	148	216	N/A
3/31/2024	1,939	147	197	266	N/A
12/31/2023	1,949	139	130	207	N/A
9/30/2023	1,965	127	142	213	N/A
6/30/2023	2,014	126	131	195	N/A
3/31/2023	2,001	130	77	133	N/A
12/31/2022	1,964	133	39	82	N/A
9/30/2022	1,866	131	33	72	N/A
6/30/2022	1,729	116	-2	35	N/A
3/31/2022	1,616	106	4	42	N/A
12/31/2021	1,483	93	54	93	N/A
9/30/2021	1,381	92	47	83	N/A
6/30/2021	1,270	81	101	135	N/A
3/31/2021	1,160	19	134	166	N/A
12/31/2020	1,193	29	116	146	N/A
9/30/2020	1,273	37	117	146	N/A
6/30/2020	1,380	55	102	131	N/A
3/31/2020	1,497	117	123	151	N/A
12/31/2019	1,513	112	131	162	N/A
9/30/2019	1,518	102	140	173	N/A
6/30/2019	1,509	92	132	168	N/A
3/31/2019	1,505	92	83	120	N/A
12/31/2018	1,477	85	75	105	N/A
9/30/2018	1,436	60	54	83	N/A
6/30/2018	1,405	63	N/A	94	N/A
3/31/2018	1,373	67	N/A	101	N/A
12/31/2017	1,307	62	N/A	83	N/A
9/30/2017	1,191	89	N/A	54	N/A
6/30/2017	1,064	77	N/A	38	N/A
3/31/2017	966	80	N/A	79	N/A
12/31/2016	883	81	N/A	106	N/A
9/30/2016	892	91	N/A	114	N/A
6/30/2016	940	115	N/A	120	N/A
3/31/2016	955	121	N/A	106	N/A
12/31/2015	1,012	120	N/A	118	N/A
9/30/2015	1,057	116	N/A	138	N/A
6/30/2015	1,031	101	N/A	128	N/A
3/31/2015	1,009	85	N/A	104	N/A
12/31/2014	961	84	N/A	106	N/A
9/30/2014	912	85	N/A	89	N/A
6/30/2014	876	78	N/A	58	N/A
3/31/2014	840	77	N/A	64	N/A
12/31/2013	819	78	N/A	61	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: IOSPDas prognostizierte Gewinnwachstum (6.9% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: IOSPDie Erträge des Unternehmens (6.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.2% pro Jahr).

Hohe Wachstumserträge: IOSPDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: IOSPDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: IOSPDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von IOSP in 3 Jahren voraussichtlich hoch sein wird

Innospec Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Innospec Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Consensus EPS estimates fall by 11%

Price target increased by 8.3% to US$138

Consensus EPS estimates fall by 16%

Price target increased to US$122

Consensus EPS estimates increase by 13%

Recent updates

Do Innospec's (NASDAQ:IOSP) Earnings Warrant Your Attention?

Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At $0.79

Dividend of US$0.79 announced

Innospec Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Pinning Down Innospec Inc.'s (NASDAQ:IOSP) P/E Is Difficult Right Now

Third quarter 2024 earnings: EPS exceeds analyst expectations

Returns On Capital At Innospec (NASDAQ:IOSP) Have Stalled

Innospec Inc. to Report Q3, 2024 Results on Nov 06, 2024

At US$110, Is Innospec Inc. (NASDAQ:IOSP) Worth Looking At Closely?

Executive VP & CFO recently sold US$1.1m worth of stock

Innospec Navigating Turbulent End-Markets And Specialty Chemical De-Rating Relatively Well

Consensus EPS estimates fall by 11%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 26% undervalued after recent price drop

Estimating The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)

Returns On Capital At Innospec (NASDAQ:IOSP) Have Hit The Brakes

Now 20% overvalued after recent price rise

Innospec Inc. to Report Q2, 2024 Results on Aug 06, 2024

Innospec Inc. to Report Q2, 2024 Results on Aug 07, 2024

Now 18% overvalued

Now 20% overvalued

Now 21% overvalued

With EPS Growth And More, Innospec (NASDAQ:IOSP) Makes An Interesting Case

Price target increased by 8.3% to US$138

Innospec (NASDAQ:IOSP) Is Increasing Its Dividend To $0.76

Dividend of US$0.76 announced

Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations

Innospec Inc.'s (NASDAQ:IOSP) Share Price Could Signal Some Risk

Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward

Innospec Inc. to Report Q1, 2024 Results on May 09, 2024

Innospec Inc. Announces Retirement of Philip Boon, Executive Vice President and Chief Operating Officer Effective March 31, 2025

Innospec Inc., Annual General Meeting, May 10, 2024

Is Innospec Inc. (NASDAQ:IOSP) Potentially Undervalued?

Estimating The Fair Value Of Innospec Inc. (NASDAQ:IOSP)

Senior VP recently sold US$314k worth of stock

President recently sold US$1.2m worth of stock

Here's Why We Think Innospec (NASDAQ:IOSP) Might Deserve Your Attention Today

Full year 2023 earnings: EPS misses analyst expectations

Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A.

Innospec (NASDAQ:IOSP) Hasn't Managed To Accelerate Its Returns

Insufficient new directors

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2023, Payable on November 27, 2023

What Does Innospec Inc.'s (NASDAQ:IOSP) Share Price Indicate?

Here's Why We Think Innospec (NASDAQ:IOSP) Is Well Worth Watching

Innospec Inc. (NASDAQ:IOSP) Shares Could Be 24% Above Their Intrinsic Value Estimate

Innospec Inc. to Report Q3, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Innospec Inc. to Report Q2, 2023 Results on Aug 08, 2023

Should You Investigate Innospec Inc. (NASDAQ:IOSP) At US$98.35?

Innospec (NASDAQ:IOSP) Is Looking To Continue Growing Its Returns On Capital

Independent Non-Executive Director exercised options and sold US$73k worth of stock

Is Innospec Inc. (NASDAQ:IOSP) Trading At A 33% Discount?

Upcoming dividend of US$0.69 per share at 1.4% yield

Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?

Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is It Time To Consider Buying Innospec Inc. (NASDAQ:IOSP)?

Now 21% undervalued after recent price drop

Investors Will Want Innospec's (NASDAQ:IOSP) Growth In ROCE To Persist

President recently sold US$2.0m worth of stock

Consensus EPS estimates fall by 16%

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?

Innospec Inc. to Report Q4, 2022 Results on Feb 21, 2023

A Look At The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)

Senior VP recently bought US$81k worth of stock

Innospec (NASDAQ:IOSP) Is Paying Out A Larger Dividend Than Last Year